Morning Journal

  News on Stocks in Our Portfolios

AbbVie beats by $0.12, beats on revenue

·         AbbVie (NYSE:ABBV): Q3 EPS of $0.89 beats by $0.12.

·         Revenue of $5.02B (+7.7% Y/Y) beats by $200M.

Rockwell Collins EPS in-line, beats on revenue

·         Rockwell Collins (NYSE:COL): FQ4 EPS of $1.27 in-line.

·         Revenue of $1.4B (+14.8% Y/Y) beats by $40M.

 

Economics

   This Week’s Data

            September personal income rose 0.2% versus expectations of 0.3%; personal spending declined 0.2% versus estimates of an increase of 0.1%.  Ooops.

   Other

Politics

  Domestic

Quote of the day (short):

http://cafehayek.com/2014/10/quotation-of-the-day-1157.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+CafeHayek+%28Cafe+Hayek%29